Precigen, Inc. (PGEN) News

Precigen, Inc. (PGEN): $0.79

0.02 (+2.37%)

POWR Rating

Component Grades

Momentum

D

Stability

C

Sentiment

Quality

D

Add PGEN to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#317 of 337

in industry

Filter PGEN News Items

PGEN News Results

Date Symbol Company Title Start End Change POWR Rating
Loading, please wait...

PGEN News Highlights

  • PGEN's 30 day story count now stands at 2.
  • Over the past 9 days, the trend for PGEN's stories per day has been choppy and unclear. It has oscillated between 1 and 1.
  • The most mentioned tickers in articles about PGEN are GENE.

Latest PGEN News From Around the Web

Below are the latest news stories about PRECIGEN INC that investors may wish to consider to help them evaluate PGEN as an investment opportunity.

Even after rising 15% this past week, Precigen (NASDAQ:PGEN) shareholders are still down 86% over the past three years

Precigen, Inc. ( NASDAQ:PGEN ) shareholders should be happy to see the share price up 16% in the last month. But the...

Yahoo | December 27, 2023

Precigen to Present at the 42nd Annual J.P. Morgan Healthcare Conference

Precigen, Inc. (Nasdaq: PGEN), a biopharmaceutical company specializing in the development of innovative gene and cell therapies to improve the lives of patients, today announced Helen Sabzevari, PhD, President and CEO of Precigen, will present a corporate and clinical overview at the 42nd Annual J.P. Morgan Healthcare Conference on Wednesday, January 10, 2024 at 5:15 PM PT/8:15 PM ET in San Francisco, California.

Yahoo | December 18, 2023

5 ‘Jackpot’ Stocks to Buy for 2024 for 10X Gains

These stocks to buy have the potential to take your portfolio to the next level thanks to the cutting-edge technology they represent.

Thomas Yeung on InvestorPlace | December 4, 2023

Precigen to Participate in the JMP Securities Hematology and Oncology Summit

Precigen, Inc. (Nasdaq: PGEN), a biopharmaceutical company specializing in the development of innovative gene and cell therapies to improve the lives of patients, today announced that Helen Sabzevari, PhD, President and CEO of Precigen, will participate in a fireside chat at the JMP Securities Hematology and Oncology Summit on Wednesday, December 6, 2023 at 3:00 PM ET.

Yahoo | November 29, 2023

3 Penny Stocks to Buy to Turn $1 into $100: November 2023

Are you looking for outsized gains for your portfolio.

Gabriel Osorio-Mazzilli on InvestorPlace | November 22, 2023

Precigen Reports Third Quarter 2023 Financial Results and Progress of Clinical Programs

Precigen, Inc. (Nasdaq: PGEN), a biopharmaceutical company specializing in the development of innovative gene and cell therapies to improve the lives of patients, today announced third quarter 2023 financial results and progress of clinical programs.

Yahoo | November 9, 2023

Precigen to Participate in the Stifel 2023 Healthcare Conference

Precigen, Inc. (Nasdaq: PGEN), a biopharmaceutical company specializing in the development of innovative gene and cell therapies to improve the lives of patients, today announced Helen Sabzevari, PhD, President and CEO of Precigen, will present a company overview at the Stifel 2023 Healthcare Conference on Wednesday, November 15, 2023 at 10:55 AM ET in New York.

Yahoo | November 7, 2023

While institutions own 26% of Precigen, Inc. (NASDAQ:PGEN), private equity firms are its largest shareholders with 37% ownership

Key Insights Precigen's significant private equity firms ownership suggests that the key decisions are influenced by...

Yahoo | September 25, 2023

Precigen to Participate in Upcoming Leading Investor and Industry Conferences

Precigen, Inc. (Nasdaq: PGEN), a biopharmaceutical company specializing in the development of innovative gene and cell therapies to improve the lives of patients, today announced Helen Sabzevari, PhD, President and CEO of Precigen, will participate in the following upcoming investor and industry conferences:

Yahoo | September 19, 2023

Fred Hassan Bought 185% More Shares In Precigen

Precigen, Inc. ( NASDAQ:PGEN ) shareholders (or potential shareholders) will be happy to see that the Independent...

Yahoo | August 17, 2023


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!